No Data
Labcorp's Q1 Revenue Surpasses Forecasts; Analysts Scrutinize Invitae Deal
Thursday, Labcorp (NYSE:LH) reported first-quarter sales increased 4.6% to $3.18 billion, beating the consensus of $3.12 billion. Base Business grew 6.7%.The increase was due to organic revenue of 2.3
Benzinga15:04 ET
Quest Diagnostics Is Maintained at Equal-Weight by Barclays
Quest Diagnostics Is Maintained at Equal-Weight by Barclays
Dow Jones14:47 ET
Barclays Maintains Equal-Weight on Quest Diagnostics, Raises Price Target to $144
Barclays analyst Stephanie Davis maintains Quest Diagnostics (NYSE:DGX) with a Equal-Weight and raises the price target from $138 to $144.
Benzinga14:36 ET
Quest Diagnostics Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 04/25/2024 6.58% Barclays $138 → $144 Maintains Equal-Weight 04/24/2024 7.32% Citigroup $135 → $145 Mainta
Benzinga14:35 ET
Leerink Partners Adjusts Laboratory Corp of America Price Target to $242 From $260, Keeps Outperform Rating
Laboratory Corp of America Holdings (LH) has an average rating of outperform and price targets ranging from $220 to $270, according to analysts polled by Capital IQ. Price: 197.56, Change: -10.38, Per
MT Newswires12:45 ET
20 Fastest Growing Health Tech Companies in the World
Yahoo FinanceApr 25 11:34 ET